SPINEART Revenue and Competitors

Plan-les-Ouates,

Location

#5504

Growjo Ranking

Estimated Revenue & Valuation

  • SPINEART's estimated annual revenue is currently $80.6M per year.(i)
  • SPINEART's estimated revenue per employee is $251,000

Employee Data

  • SPINEART has 321 Employees.(i)
  • SPINEART grew their employee count by 5% last year.

SPINEART's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP FinanceReveal Email/Phone
3
EVP, RAQAReveal Email/Phone
4
VP Market Development StrategyReveal Email/Phone
5
SVP Sales OUS (Europe, Middle East Africa, Latin America, Asia Pacific)Reveal Email/Phone
6
VP DistributionReveal Email/Phone
7
VP Research And DevelopmentReveal Email/Phone
8
VP EducationReveal Email/Phone
9
VP SalesReveal Email/Phone
10
VP Global Quality Product at SPINEARTReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is SPINEART?

Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.

keywords:N/A

N/A

Total Funding

321

Number of Employees

$80.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SPINEART News

2022-04-20 - Globus Medical CEO shift, new artificial disc data and more: 8 ...

... treated in an ongoing investigational device exemption clinical trial of Spineart USA's Baguera C cervical disc in the single level.

2022-04-17 - Spineart-100 US Patients Treated In The Single Level IDE ...

Spineart is currently conducting, in parallel, a single-level and two-level IDE Clinical Trial of the BAGUERA ® C Cervical Disc Prosthesis...

2022-04-13 - 100 US PATIENTS TREATED IN THE SINGLE LEVEL IDE ...

Spineart is currently conducting, in parallel, a single-level and two-level IDE Clinical Trial of the BAGUERA ® C Cervical Disc Prosthesis at...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$124.3M4169%N/A
#2
$710.9M20239%N/A